Concepedia

Vincent C.O. Njar

VC

Statistics

Publications

82

Citations

10K

H-Index

37

Active since

1983

Affiliations

University of Maryland, Baltimore(Current)

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Thomas Jefferson University

U-M Rogel Cancer Center

Sidney Kimmel Cancer Center

Vincent C.O. Njar is an author at University of Maryland, Baltimore specializing in pharmacology, medicine, and oncology.

ORCID

Publications per year

1983–2023

82

Publications

82

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe et al. · Autophagy · 2016 · 6K citations · Full text

, , +9

Regulation of androgen receptor activity by tyrosine phosphorylation

Zhiyong Guo, Bojie Dai, Tianyun Jiang et al. · Cancer Cell · 2006 · 361 citations · Full text

, , +14

Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens:  Synthesis, in Vitro Biological Activity, Pharmacokinetics, and Antitumor Activity in the LAPC4 Human Prostate Cancer Xenograft Model

Venkatesh Handratta, Tadas S. Vasaitis, Vincent C.O. Njar et al. · Journal of Medicinal Chemistry · 2005 · 247 citations · Full text

, , +17

Promise and challenges in drug discovery and development of hybrid anticancer drugs

Lalji K. Gediya, Vincent C.O. Njar · Expert Opinion on Drug Discovery · 2009 · 220 citations

, , +15

Discovery and Development of Galeterone (TOK-001 or VN/124-1) for the Treatment of All Stages of Prostate Cancer

Vincent C.O. Njar, Angela Brodie · Journal of Medicinal Chemistry · 2015 · 201 citations · Full text

, , +17

1–5 of 82